Femasys Inc. (FEMY)Healthcare | Medical Instruments & Supplies | Suwanee, United States | NasdaqCM
0.42 USD
+0.00
(0.118%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:33 p.m. EDT
Avoid this distressed biotech play completely; the company is fundamentally broken with negative earnings, negative cash flow, and surgical share dilution, offering no reliable profit potential in the foreseeable future. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.266760 |
| AutoTheta | 0.266790 |
| AutoARIMA | 0.269795 |
| MSTL | 0.285008 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 53% |
| H-stat | 2.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.080 |
| Excess Kurtosis | 0.13 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 80.026 |
| Revenue per Share | 0.058 |
| Market Cap | 25,629,808 |
| Forward P/E | -1.20 |
| Beta | -2.28 |
| Website | https://www.femasys.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.652459 |
| Address1 | 3,950 Johns Creek Court |
| Address2 | Suite 100 |
| All Time High | 13.75 |
| All Time Low | 0.248 |
| Ask | 0.5443 |
| Ask Size | 2 |
| Average Analyst Rating | 1.7 - Buy |
| Average Daily Volume10 Day | 375,920 |
| Average Daily Volume3 Month | 545,918 |
| Average Volume | 545,918 |
| Average Volume10Days | 375,920 |
| Beta | -2.277 |
| Bid | 0.294 |
| Bid Size | 2 |
| Book Value | 0.098 |
| City | Suwanee |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4244 |
| Current Ratio | 4.526 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.4274 |
| Day Low | 0.4111 |
| Debt To Equity | 80.026 |
| Display Name | Femasys |
| Ebitda | -17,246,636 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.221 |
| Enterprise To Revenue | 9.183 |
| Enterprise Value | 21,060,418 |
| Eps Current Year | -0.365 |
| Eps Forward | -0.355 |
| Eps Trailing Twelve Months | -0.47 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 404 581 5903 |
| Fifty Day Average | 0.50058 |
| Fifty Day Average Change | -0.07618001 |
| Fifty Day Average Change Percent | -0.15218349 |
| Fifty Two Week Change Percent | -65.2459 |
| Fifty Two Week High | 1.29 |
| Fifty Two Week High Change | -0.8656 |
| Fifty Two Week High Change Percent | -0.67100775 |
| Fifty Two Week Low | 0.307 |
| Fifty Two Week Low Change | 0.11739999 |
| Fifty Two Week Low Change Percent | 0.38241038 |
| Fifty Two Week Range | 0.307 - 1.29 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,624,023,000,000 |
| Float Shares | 49,925,584 |
| Forward Eps | -0.355 |
| Forward P E | -1.195493 |
| Free Cashflow | -11,906,741 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 51 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.61959 |
| Gross Profits | 1,420,913 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09278 |
| Held Percent Institutions | 0.102740005 |
| Implied Shares Outstanding | 60,390,686 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,021-06-18 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. |
| Long Name | Femasys Inc. |
| Market | us_market |
| Market Cap | 25,629,808 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_61212730 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -18,627,888 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 25,919,682 |
| Number Of Analyst Opinions | 3 |
| Open | 0.42 |
| Operating Cashflow | -18,690,564 |
| Operating Margins | -5.68331 |
| Payout Ratio | 0.0 |
| Phone | 770 500 3910 |
| Pre Market Change | -0.0042999983 |
| Pre Market Change Percent | -1.0131947 |
| Pre Market Price | 0.4201 |
| Pre Market Time | 1,776,775,446 |
| Previous Close | 0.4239 |
| Price Eps Current Year | -1.1627398 |
| Price Hint | 4 |
| Price To Book | 4.330612 |
| Price To Sales Trailing12 Months | 11.175887 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.787 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.66667 |
| Region | US |
| Regular Market Change | 0.0005 |
| Regular Market Change Percent | 0.117951 |
| Regular Market Day High | 0.4274 |
| Regular Market Day Low | 0.4111 |
| Regular Market Day Range | 0.4111 - 0.4274 |
| Regular Market Open | 0.42 |
| Regular Market Previous Close | 0.4239 |
| Regular Market Price | 0.4244 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 194,830 |
| Return On Assets | -0.66283995 |
| Return On Equity | -4.55799 |
| Revenue Growth | 0.399 |
| Revenue Per Share | 0.058 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 60,390,686 |
| Shares Percent Shares Out | 0.0337 |
| Shares Short | 2,033,876 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,940,365 |
| Short Name | Femasys Inc. |
| Short Percent Of Float | 0.0352 |
| Short Ratio | 3.03 |
| Source Interval | 15 |
| State | GA |
| Symbol | FEMY |
| Target High Price | 6.5 |
| Target Low Price | 1.5 |
| Target Mean Price | 3.66667 |
| Target Median Price | 3.0 |
| Total Cash | 9,266,353 |
| Total Cash Per Share | 0.153 |
| Total Debt | 4,696,964 |
| Total Revenue | 2,293,313 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.47 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.638235 |
| Two Hundred Day Average Change | -0.21383497 |
| Two Hundred Day Average Change Percent | -0.33504114 |
| Type Disp | Equity |
| Volume | 194,830 |
| Website | https://www.femasys.com |
| Zip | 30,024 |